A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

Completed · Phase 4

Conditions studied: Healthy Volunteers

In brief

To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects

Key facts

Study ID

NCT00251030

Run by

Pfizer

People needed

20

Starts

2005-11-01

Expected to finish

2006-01-01

Last updated by the study team

2009-02-16

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female subjects between the ages of 18 and 55 years.

You may not qualify if…

• Subjects with hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.

Where it is running

• Pfizer Investigational Site — Kalamazoo, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.